Total time at risk, years
|
1,3851.47
| |
2,5049.24
| |
Median follow-up, yearsa
|
7.75
|
(0.56–10)b
|
7.45
|
(0.48–10)b
|
Median time at risk, years
|
6.47
|
(0.10–9.64)b
|
5.70
|
(0.03–9.77)b
|
Median time from diagnosis to study entry, years
|
0.73
|
(0.00–8.64)b
|
1.16
|
(0.00–9.34)b
|
Number of deaths
|
359
| |
637
| |
Annual mortality rate
|
0.026
| |
0.025
| |
5-year survival rate
|
0.88
|
(0.86–0.89)c
|
0.88
|
(0.87–0.89)c
|
Median age at diagnosis, years
|
50.2
|
(25–69)b
|
51.0
|
(23–69)b
|
Age at diagnosis, years
| | | | |
<40
|
212
|
9.30%
|
394
|
8.81%
|
40–49
|
753
|
33.20%
|
1,331
|
29.78%
|
50–59
|
997
|
43.90%
|
1,802
|
40.31%
|
60+
|
308
|
13.60%
|
943
|
21.10%
|
Histopathological grade
| | | | |
Well differentiated
|
434
|
19.11%
|
871
|
19.49%
|
Moderately differentiated
|
787
|
34.67%
|
1,687
|
37.74%
|
Poorly differentiated
|
504
|
22.20%
|
1,019
|
22.80%
|
Unknown
|
545
|
24.00%
|
893
|
19.98%
|
Morphological type
| | | | |
Ductal
|
1,674
|
73.74%
|
3,316
|
74.18%
|
Lobular
|
351
|
15.46%
|
659
|
14.74%
|
Other
|
222
|
9.78%
|
455
|
10.17%
|
Unknown
|
23
|
1.01%
|
40
|
0.89%
|
Clinical stage
| | | | |
1
|
1,112
|
48.99%
|
2,190
|
48.99%
|
2
|
986
|
43.33%
|
1,981
|
44.32%
|
3 or 4
|
172
|
7.58%
|
194
|
4.34%
|
Missing
|
0
|
0%
|
105
|
2.35%
|